semaglutide warnings FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy The package insert for Ozempic

The epidemic rise in the prevalence of obesity has metabolic consequences and is paralleled by an increased occurrence of other diseases, such as diabetes, cancer and cardiovascular complications

Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

Discover how tirzepatide and erectile dysfunction are connected

It is usually used as a diagnostic test to evaluate the ability to secrete growth hormone, but can also treat growth hormone deficiency in children

If youre on any kind of GLP-1 therapy for weight loss, you might have found your appetite has taken a nosedive

Semaglutide 5mg: Selective GLP-1 Receptor Agonist Research Compound